What after Lee Zane's Insider Unload of Anacor Pharmaceuticals Inc (NASDAQ

What after Lee Zane's Insider Unload of Anacor Pharmaceuticals Inc (NASDAQ … The Company's lead product candidate, AN2728 is an investigational non-steroidal topical PDE-4 inhibitor in development for the potential treatment of mild-to-moderate atopic dermatitis and psoriasis. The Company's product … Continue reading

Posted in Flea Protection Media | Tagged , , , , , , , | Leave a comment

Anacor Pharmaceuticals to Present at Upcoming Investor Conferences

Anacor Pharmaceuticals to Present at Upcoming Investor Conferences Anacor's first approved drug, KERYDIN® (tavaborole) topical solution, 5%, is an oxaborole antifungal approved by the U.S. Food and Drug Administration in July 2014 for the topical treatment of onychomycosis of the … Continue reading

Posted in Flea Protection Media | Tagged , , , , , | Leave a comment